Please login to the form below

Not currently logged in
Email:
Password:

Vokanamet

This page shows the latest Vokanamet news and features for those working in and with pharma, biotech and healthcare.

FDA approves J&J’s diabetes combo

FDA approves J&J’s diabetes combo

The FDA approval follows the decision by the European Commission in April this year to approval a combination of canagliflozin and metformin under the name Vokanamet.

Latest news

  • Boehringer/Lilly's Jardiance approved in US Boehringer/Lilly's Jardiance approved in US

    Both these products are also available as combination treatments with metformin in versions called Vokanamet (Invokana and metformin) and Xigduo (Forxiga and metformin).

  • NICE backs Janssen’s once-daily diabetes drug NICE backs Janssen’s once-daily diabetes drug

    Janssen's Invokana was also granted European approval for a fixed dose combination with metformin that will be marketed as Vokanamet, putting it on an equal setting to AstraZeneca, which markets

  • EC approves drugs for diabetes and Crohn’s disease EC approves drugs for diabetes and Crohn’s disease

    Both these products are also available as combination treatments with metformin in versions called Vokanamet (Invokana and metformin) and Xigduo (Forxiga and metformin).

  • J&J wins EU approval for diabetes combo J&J wins EU approval for diabetes combo

    J&J wins EU approval for diabetes combo. Vokanamet combines Invokana and metformin. ... Johnson &Johnson's diabetes portfolio continues to grow apace with the news that its combination treatment Vokanamet has been approved in the EU.

  • Janssen Invokana combination recommended for European approval Janssen Invokana combination recommended for European approval

    The CHMP's positive opinion on Vokanamet puts the type 2 diabetes treatment on the path to full approval in the region within the next three months. ... The company will have to implement a pharmacovigilance plan for Vokanamet as part of any marketing

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics